China has cut value-added tax (VAT) to 3% on imports, production and sales of the second batch of anti-cancer and rare diseases drugs in a bid to lower costs for patients and boost its pharmaceutical industry, customs said on Thursday.
Source: todayonline.com
Latest Posts in "China"
- China and Vietnam Sign Customs Cooperation Agreement to Combat Smuggling and Facilitate Trade
- China Clarifies VAT Threshold Under New VAT Law
- China’s E‑Fapiao System: A Comprehensive Guide to Digital VAT Invoicing and Compliance
- China’s New VAT Rules: Key Compliance Changes and Deadlines for Businesses from 2026
- China Updates VAT Administration: New Law, SME Enforcement, E-Commerce Relief, Import Incentives Extended
